Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular ...

In the Phase III SELECT-GCA trial, Rinvoq (upadacitinib) 15 mg with a 26-week glucocorticoid taper significantly improved ...

The biosimilar of IL-6 inhibitor tocilizumab, called Tyenne (formerly MSB11456), has been approved for the same indications as Roche’s brand, including rheumatoid arthritis, systemic juvenile ...

2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo-controlled trial (RADIATE) of patients with RA who ...

Antibodies that interfere with IL-6 function Tocilizumab is a monoclonal antibody directed against the IL-6 receptor that has established benefit in RA both with regards to clinical efficacy and ...

There was already some evidence for that in the fourth quarter, with Actemra (tocilizumab) – used to treat severe COVID-19 – down 22% to CHF 2.7 billion. The outgoing CEO acknowledged pipeline ...

On April 17, 2025, the Supreme Court resolved a circuit split on the appropriate pleading standard for a specific type of prohibited transaction ...

Does infusion therapy is really safe? For treating autoimmune disease and reduce the root cause, yes infusion therapy is safe ...

JERSEY CITY, N.J., April 15, 2025--Organon announces the appointment of Ramona A. Sequeira to the company's Board of Directors, effective July 1, 2025. JERSEY CITY, N ...

CRS was managed with steroids (75%), tocilizumab (100%), and anakinra (25%). One event (85%) reportedly occurred of grade 1 immune effector cell-associated neurotoxicity. Two grade 5 events were ...

Case reports The anti-interleukin (IL)−6 receptor antibody, tocilizumab, is a biological agent Food and Drug Administration approved for the treatment of rheumatoid arthritis and juvenile idiopathic ...